Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics

Reference Laboratory Services

We understand how important it is to accelerate the approval and commercialization of your therapies. That's why our goal is to rapidly deliver solutions that meet your timelines and regulatory requirements, while at the same time support your commercialization strategies, even when those strategies change.

MolecularMD performs oncology biomarker diagnostic testing designed and validated to meet the clinical requirements of standardization, sensitivity, and specificity. All of our assays are not only trusted by the most demanding clinicians, but also valued by drug development sponsors for their critical regulatory submissions.


  • Rapid turnaround
  • Clear, easy-to-interpret diagnostic reports
  • Responsive customer service
  • Comprehensive billing support


  • Quantitative RT-PCR
  • Sequencing (Sanger, Next-Gen)
  • Allele Specific PCR
  • Immunohistochemistry


Test Ordering

Contact MolecularMD for more information about our Reference Laboratory Services

MolecularMD discusses the clinical application of liquid biopsy or circulating tumor DNA (ctDNA) and its benefits within the field of oncology and companion diagnostics.